Home
Advanced Search
Help
Update History
Statistics
Downloads
The Barton Group

Predicted interactions involving protein CRKL: Crk-like protein (IPI00004839) that score above 1.0

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module ScoreDatabases
Where interaction is observed in another database a link is provided:

Protein 1 (?)Protein 2 (?) Name of Protein 2 Module Scores (?) Scores (?) Evidence (?) Database (?)
CRKL PDGFRB PDGFRB: Beta-type platelet-derived growth factor receptor precursor 1.22E5 Evidence
CRKL STAT5A STAT5A, STAT5: Signal transducer and activator of transcription 5A 9.84E4 Evidence O
CRKL KIT KIT: Mast/stem cell growth factor receptor precursor 8.90E4 Evidence O
CRKL PDGFRA PDGFRA: Alpha-type platelet-derived growth factor receptor precursor 6.45E4 Evidence
CRKL INSR INSR: Insulin receptor precursor 6.35E4 Evidence
CRKL CSF1R CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor 5.39E4 Evidence
CRKL NCK2 NCK2: Cytoplasmic protein NCK2 1.50E4 Evidence
CRKL STAT1 STAT1: Signal transducer and activator of transcription 1-alpha/beta 1.07E4 Evidence
CRKL FRS3 FRS3: Fibroblast growth factor receptor substrate 3 7.83E3 Evidence
CRKL WASPIP N/A 3.35E3 Evidence
CRKL WAS WAS, IMD2: Wiskott-Aldrich syndrome protein 3.35E3 Evidence O
CRKL HCLS1 HCLS1, HS1: Hematopoietic lineage cell-specific protein 2.03E3 Evidence
CRKL BCAR1 BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 2.01E3 Evidence O
CRKL WASL WASL: Neural Wiskott-Aldrich syndrome protein 816.0 Evidence
CRKL SHC3 SHC3, NSHC, SHCC: SHC-transforming protein 3 688.0 Evidence
CRKL BTK BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK 674.0 Evidence
CRKL FLT1 FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor 519.0 Evidence
CRKL LCK LCK: Proto-oncogene tyrosine-protein kinase LCK 455.0 Evidence
CRKL CSK CSK: Tyrosine-protein kinase CSK 408.0 Evidence
CRKL JAK1 407.0 Evidence
CRKL SYK SYK: Tyrosine-protein kinase SYK 407.0 Evidence
CRKL JAK2 JAK2: Tyrosine-protein kinase JAK2 407.0 Evidence
CRKL CTTN CTTN, EMS1: Src substrate cortactin 331.0 Evidence
CRKL PTK2 PTK2, FAK, FAK1: Focal adhesion kinase 1 320.0 Evidence
CRKL ABL1 ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 275.0 Evidence
CRKL SRC SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src 275.0 Evidence
CRKL TYK2 TYK2: Non-receptor tyrosine-protein kinase TYK2 268.0 Evidence
CRKL FYN FYN: Proto-oncogene tyrosine-protein kinase Fyn 268.0 Evidence
CRKL LYN LYN: Tyrosine-protein kinase Lyn 247.0 Evidence
CRKL TEC TEC, PSCTK4: Tyrosine-protein kinase Tec 246.0 Evidence
CRKL YES1 YES1, YES: Proto-oncogene tyrosine-protein kinase Yes 246.0 Evidence
CRKL HCK N/A 246.0 Evidence
CRKL EPHB1 EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor 240.0 Evidence
CRKL INSL3 JAK3: Tyrosine-protein kinase JAK3 223.0 Evidence
CRKL EPHA7 EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor 216.0 Evidence
CRKL ZAP70 ZAP70: Uncharacterized protein ZAP70 187.0 Evidence O
CRKL FGR FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR 187.0 Evidence
CRKL BMX N/A 177.0 Evidence
CRKL PTK2B PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta 139.0 Evidence
CRKL ERBB4 ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor 134.0 Evidence
CRKL TEK TEK, TIE2: Angiopoietin-1 receptor precursor 132.0 Evidence
CRKL WIRE WIPF2, WICH, PP10631, WIRE: WAS/WASL-interacting protein family member 2 123.0 Evidence
CRKL EGFR EGFR, ERBB1: Epidermal growth factor receptor precursor 121.0 Evidence
CRKL STAT6 STAT6: Signal transducer and activator of transcription 6 114.0 Evidence
CRKL ITK ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK 106.0 Evidence
CRKL KDR KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor 90.80 Evidence
CRKL CD2AP CD2AP: CD2-associated protein 85.20 Evidence
CRKL KHDRBS1 KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate 80.90 Evidence
CRKL IGF1R IGF1R: Insulin-like growth factor 1 receptor precursor 80.00 Evidence
CRKL MAPK1 MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 64.00 Evidence
CRKL PTEN PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du 62.90 Evidence
CRKL STAT5B STAT5B: Signal transducer and activator of transcription 5B 56.20 Evidence
CRKL RAF1 RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase 51.60 Evidence
CRKL DOK1 DOK1: Docking protein 1 51.50 Evidence
CRKL PIK3CG PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i 51.50 Evidence
CRKL SPTA1 SPTA1, SPTA: Spectrin alpha chain, erythrocyte 43.60 Evidence
CRKL MAP3K8 MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 43.60 Evidence
CRKL CSNK2A1 CSNK2A1: CSNK2A1 protein 42.00 Evidence
CRKL CBLB CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B 41.50 Evidence
CRKL GRAP2 GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 39.10 Evidence
CRKL CSNK1E CSNK1E: Casein kinase I isoform epsilon 39.10 Evidence
CRKL VAV1 VAV1, VAV: Proto-oncogene vav 38.10 Evidence
CRKL NCK1 NCK1, NCK: Cytoplasmic protein NCK1 38.10 Evidence
CRKL IL10RA IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor 37.90 Evidence
CRKL TLK1 TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 37.80 Evidence
CRKL LNK SH2B3, LNK: SH2B adapter protein 3 37.80 Evidence
CRKL PTPN6 PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 37.80 Evidence
CRKL RASA1 RASA1, RASA: Ras GTPase-activating protein 1 33.90 Evidence
CRKL DUSP16 DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 33.90 Evidence
CRKL STAT3 33.90 Evidence
CRKL ACP1 ACP1: Low molecular weight phosphotyrosine protein phosphatase 32.30 Evidence
CRKL APS SH2B2, APS: SH2B adapter protein 2 31.20 Evidence
CRKL IL2RB IL2RB: Interleukin-2 receptor subunit beta precursor 28.70 Evidence
CRKL EPOR EPOR: Erythropoietin receptor precursor 28.70 Evidence
CRKL CSF2RB CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor 28.70 Evidence
CRKL MAG MAG, GMA: Myelin-associated glycoprotein precursor 28.70 Evidence
CRKL HLA-C HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor 28.00 Evidence
CRKL MAP4K1 MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 27.90 Evidence O
CRKL STK4 STK4, MST1: Serine/threonine-protein kinase 4 26.80 Evidence
CRKL PTPN1 PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 25.70 Evidence
CRKL ROBO1 ROBO1, DUTT1: Roundabout homolog 1 precursor 25.70 Evidence
CRKL PRKCA PRKCA, PKCA, PRKACA: Protein kinase C alpha type 25.3 Evidence
CRKL MAPK3 MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 25.3 Evidence
CRKL CD247 CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor 24.90 Evidence
CRKL PTPN12 PTPN12: Tyrosine-protein phosphatase non-receptor type 12 23.70 Evidence
CRKL CCR5 CCR5: CCR5 receptor (Fragment) 22.90 Evidence
CRKL GHR GHR: Growth hormone receptor precursor 22.90 Evidence
CRKL BLNK BLNK, BASH, SLP65: B-cell linker protein 22.80 Evidence
CRKL VASP VASP: Vasodilator-stimulated phosphoprotein 22.80 Evidence
CRKL PSTPIP1 PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 22.80 Evidence
CRKL L1CAM L1CAM, CAML1, MIC5: Neural cell adhesion molecule L1 precursor 22.30 Evidence
CRKL PTPRF PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor 22.30 Evidence
CRKL PTPN2 PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 22.30 Evidence
CRKL PRKCG PRKCG, PKCG: Protein kinase C gamma type 22.20 Evidence
CRKL PIK3R2 PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta 22.20 Evidence O
CRKL GAB1 GAB1: GRB2-associated-binding protein 1 21.10 Evidence
CRKL SOCS3 SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 21.10 Evidence
CRKL GRB2 GRB2, ASH: Growth factor receptor-bound protein 2 20.50 Evidence
CRKL SH3KBP1 SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 20.50 Evidence
CRKL RAPGEF6 RAPGEF6, PDZGEF2: Rap guanine nucleotide exchange factor 6 20.50 Evidence
CRKL ABCF1 N/A 19.90 Evidence
CRKL LCP2 LCP2: Lymphocyte cytosolic protein 2 19.70 Evidence
CRKL CEBPA CEBPA: CCAAT/enhancer-binding protein alpha 18.60 Evidence
CRKL ALCAM ALCAM, MEMD: CD166 antigen precursor 18.60 Evidence
CRKL RARS RARS: Arginyl-tRNA synthetase, cytoplasmic 17.80 Evidence
CRKL USP10 USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 17.80 Evidence
CRKL MLH1 MLH1, COCA2: DNA mismatch repair protein Mlh1 17.80 Evidence
CRKL SLA SLA, SLAP, SLAP1: SRC-like-adapter 17.30 Evidence
CRKL SH3BP2 SH3BP2: Uncharacterized protein SH3BP2 17.30 Evidence
CRKL FXR1 FXR1: Fragile X mental retardation syndrome-related protein 1 17.10 Evidence
CRKL IRS2 IRS2: Insulin receptor substrate 2 17.10 Evidence
CRKL KCNJ12 KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 16.60 Evidence
CRKL STIP1 STIP1: Stress-induced-phosphoprotein 1 16.10 Evidence
CRKL PRKCQ PRKCQ, PRKCT: Protein kinase C theta type 15.50 Evidence
CRKL NMI NMI: N-myc-interactor 15.30 Evidence
CRKL VCAM1 VCAM1, L1CAM: Vascular cell adhesion protein 1 precursor 15.10 Evidence
CRKL MAP2K5 N/A 15.00 Evidence
CRKL CBL CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL 14.60 Evidence O
CRKL COPA COPA: Coatomer subunit alpha 14.40 Evidence
CRKL PTPN11 N/A 14.40 Evidence
CRKL DPF2 DPF2, REQ, UBID4: Zinc finger protein ubi-d4 14.40 Evidence
CRKL USP47 USP47: Ubiquitin carboxyl-terminal hydrolase 47 14.40 Evidence
CRKL SYN3 SYN3: Synapsin-3 14.30 Evidence
CRKL PRKAA1 N/A 13.80 Evidence
CRKL BUB1 13.70 Evidence
CRKL IRS1 IRS1: Insulin receptor substrate 1 13.50 Evidence
CRKL PTPRC PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ 13.50 Evidence
CRKL SOS1 SOS1: Son of sevenless homolog 1 13.50 Evidence O
CRKL CNKSR2 CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 13.50 Evidence
CRKL ITSN2 ITSN2, KIAA1256, SH3D1B, SWAP: Intersectin-2 13.40 Evidence
CRKL PKN3 PKN3, PKNBETA: Serine/threonine-protein kinase N3 13.40 Evidence
CRKL ELMO1 N/A 13.40 Evidence
CRKL BIN1 BIN1, AMPHL: Myc box-dependent-interacting protein 1 13.40 Evidence
CRKL PLCB1 PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- 12.10 Evidence
CRKL IL2RG IL2RG: Cytokine receptor common gamma chain precursor 12.00 Evidence
CRKL PRKDC PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit 11.90 Evidence
CRKL GRB10 N/A 11.70 Evidence
CRKL EVL EVL, RNB6: Ena/VASP-like protein 11.70 Evidence
CRKL NULL Ig lambda chain V-II region NEI 11.70 Evidence
CRKL ACVR1B ACVR1B, ACVRLK4: Activin receptor type-1B precursor 11.60 Evidence
CRKL ADRB2 ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor 11.60 Evidence
CRKL STAT2 STAT2: Signal transducer and activator of transcription 2 11.40 Evidence
CRKL TNFSF13B TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto 11.20 Evidence
CRKL PRKD1 PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 10.80 Evidence
CRKL TGFBR1 TGFBR1: TGF-beta receptor type-1 precursor 10.70 Evidence
CRKL PPP2CA PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform 10.60 Evidence
CRKL HIST3H3 HIST3H3, H3FT: Histone H3.1t 10.20 Evidence
CRKL UBTF UBTF, UBF, UBF1: Nucleolar transcription factor 1 10.20 Evidence
CRKL FABP4 FABP4: Fatty acid-binding protein, adipocyte 10.10 Evidence
CRKL TIAM1 TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 10.10 Evidence
CRKL BRCA2 BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein 9.73 Evidence
CRKL VCPIP1 VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 9.73 Evidence
CRKL IGFBP7 IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor 9.33 Evidence
CRKL FNBP1 N/A 9.18 Evidence
CRKL CEACAM1 CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr 8.96 Evidence
CRKL HSPB8 HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 8.86 Evidence
CRKL SOCS2 SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 8.32 Evidence
CRKL RASA4 RASA4, CAPRI, GAPL, KIAA0538: Ras GTPase-activating protein 4 8.32 Evidence
CRKL FRS2 FRS2: Fibroblast growth factor receptor substrate 2 7.87 Evidence
CRKL CTLA4 CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor 7.74 Evidence
CRKL DCC DCC: Netrin receptor DCC precursor 7.66 Evidence
CRKL SNCA SNCA, NACP, PARK1: Alpha-synuclein 7.59 Evidence
CRKL CALM2 CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca 7.50 Evidence
CRKL PIM1 N/A 7.18 Evidence
CRKL GSR GSR, GLUR, GRD1: Glutathione reductase, mitochondrial precursor 7.10 Evidence
CRKL CCT4 CCT4, CCTD, SRB: T-complex protein 1 subunit delta 7.10 Evidence
CRKL LRRC7 LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7 6.80 Evidence
CRKL SCARB2 SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 6.63 Evidence
CRKL MAP4K3 MAP4K3, RAB8IPL1: Mitogen-activated protein kinase kinase kinase kinase 3 6.54 Evidence
CRKL YWHAB YWHAB: 14-3-3 protein beta/alpha 6.45 Evidence
CRKL SOCS1 SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 6.31 Evidence
CRKL GRAP GRAP: GRB2-related adapter protein 6.31 Evidence
CRKL VAV3 VAV3: Protein vav-3 6.31 Evidence
CRKL C9orf88 N/A 6.14 Evidence
CRKL ARHGEF1 ARHGEF1: Rho guanine nucleotide exchange factor 1 6.11 Evidence
CRKL SRA1 APBB3, FE65L2: Amyloid beta A4 precursor protein-binding family B member 3 6.11 Evidence
CRKL RASGRF2 RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) 6.11 Evidence
CRKL ASB6 ASB6: Ankyrin repeat and SOCS box protein 6 6.11 Evidence
CRKL BRDG1 STAP1, BRDG1: Signal-transducing adaptor protein 1 6.11 Evidence
CRKL MYH9 MYH9: Myosin-9 6.06 Evidence
CRKL DOCK1 DOCK1: Dedicator of cytokinesis protein 1 5.89 Evidence
CRKL EEF1A1 EEF1A1: Elongation factor 1-alpha 5.74 Evidence
CRKL GJA5 GJA5: Gap junction alpha-5 protein 5.66 Evidence
CRKL IGFBP5 IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor 5.06 Evidence
CRKL NR3C1 NR3C1, GRL: Glucocorticoid receptor 4.99 Evidence
CRKL TERF2IP TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 4.98 Evidence
CRKL SCAP2 SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 4.84 Evidence
CRKL C20orf75 C20orf75: Uncharacterized protein C20orf75 precursor 4.80 Evidence
CRKL TRPV3 TRPV3: Transient receptor potential cation channel subfamily V member 3 4.80 Evidence
CRKL CD200R1 CD200R1, CD200R, CRTR2, MOX2R, OX2R: Cell surface glycoprotein OX2 receptor prec 4.80 Evidence
CRKL BTLA BTLA: B- and T-lymphocyte attenuator precursor 4.80 Evidence
CRKL CSPG2 N/A 4.67 Evidence
CRKL SOCS5 SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 4.56 Evidence
CRKL BRCA1 BRCA1, RNF53: Breast cancer type 1 susceptibility protein 4.47 Evidence
CRKL EP300 N/A 4.47 Evidence
CRKL THOP1 THOP1: Thimet oligopeptidase 4.23 Evidence
CRKL GPI GPI: Glucose-6-phosphate isomerase 4.23 Evidence
CRKL CHN2 CHN2, ARHGAP3, BCH: Beta-chimaerin 4.08 Evidence
CRKL GRB14 GRB14: Growth factor receptor-bound protein 14 4.07 Evidence
CRKL GRB7 GRB7: Growth factor receptor-bound protein 7 4.01 Evidence
CRKL TRAF2 TRAF2, TRAP3: TNF receptor-associated factor 2 3.87 Evidence
CRKL SH2D1A SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A 3.69 Evidence
CRKL ESRRA ESRRA, ERR1, ESRL1, NR3B1: Steroid hormone receptor ERR1 3.39 Evidence
CRKL ITGA2B ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor 3.39 Evidence
CRKL SNAP25 N/A 3.28 Evidence
CRKL CSF3R N/A 3.28 Evidence
CRKL PCDHA2 PCDHA2: Protocadherin alpha 2 precursor 3.28 Evidence
CRKL EDNRB EDNRB, ETRB: Endothelin B receptor precursor 3.28 Evidence
CRKL SHB SHB: SH2 domain-containing adapter protein B 3.24 Evidence
CRKL S100B S100B: Protein S100-B 3.13 Evidence
CRKL PARVA PARVA, MXRA2: Alpha-parvin 3.04 Evidence
CRKL CAV1 CAV1, CAV: Caveolin-1 2.95 Evidence
CRKL DDX41 DDX41, ABS: Probable ATP-dependent RNA helicase DDX41 2.93 Evidence
CRKL BTAF1 BTAF1, TAF172: TATA-binding protein-associated factor 172 2.93 Evidence
CRKL APP APP, A4, AD1: Amyloid beta A4 protein precursor 2.93 Evidence
CRKL IFNAR2 N/A 2.90 Evidence
CRKL CEBPB CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta 2.70 Evidence
CRKL GLG1 GLG1: Golgi apparatus protein 1 2.6 Evidence
CRKL CDC42 N/A 2.54 Evidence
CRKL RGS2 RGS2, G0S8: Regulator of G-protein signaling 2 2.34 Evidence
CRKL SMAD3 SMAD3, MADH3: Mothers against decapentaplegic homolog 3 2.33 Evidence
CRKL CREBBP CREBBP, CBP: CREB-binding protein 2.33 Evidence
CRKL ARPC1B ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B 2.33 Evidence
CRKL RAC1 N/A 2.28 Evidence
CRKL FCER1G FCER1G: High affinity immunoglobulin epsilon receptor subunit gamma precursor 2.20 Evidence
CRKL DOK3 N/A 2.17 Evidence
CRKL GIT1 GIT1: ARF GTPase-activating protein GIT1 2.10 Evidence
CRKL CHST7 CHST7: Carbohydrate sulfotransferase 7 1.76 Evidence
CRKL RAB4B RAB4B, PP1596: Ras-related protein Rab-4B 1.48 Evidence
CRKL ITGB3 ITGB3, GP3A: Integrin beta-3 precursor 1.32 Evidence
CRKL EWSR1 EWSR1, EWS: RNA-binding protein EWS 1.18 Evidence
CRKL NGFR NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor 1.17 Evidence
CRKL ITGAV ITGAV, MSK8, VNRA: Integrin alpha-V precursor 1.17 Evidence
CRKL TXK TXK, PTK4: Tyrosine-protein kinase TXK 1.17 Evidence
CRKL PPP1CB PPP1CB: Serine/threonine-protein phosphatase PP1-beta catalytic subunit 1.14 Evidence
CRKL MATK MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase 1.13 Evidence
CRKL ABL2 ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 1.13 Evidence
CRKL ANXA6 ANXA6, ANX6: Annexin A6 1.13 Evidence
CRKL SHC2 N/A 1.12 Evidence